ARTICLE | Finance
Global access
How Vivo could help Chinese cancer, autoimmune play InnoCare go global
February 16, 2018 9:18 PM UTC
Vivo Capital could help InnoCare Pharma Ltd. seek global development partners as the Chinese cancer and autoimmune company evaluates its first four candidates in the clinic.
Vivo, a new investor, led an untranched $55 million venture round for InnoCare on Feb. 9. Seed investor Jianxin Capital also participated...
BCIQ Company Profiles